Keywords: IVIM, Breast
Motivation: Radiomics research based on whole tumors is limited by the unclear biological significance of radiomics features, which therefore lack clinical interpretability.
Goal(s): We aimed to determine whether features extracted from subregions defined by habitat imaging could identify breast cancer patients who will benefit from neoadjuvant chemotherapy (NAC).
Approach: We builded models for predicting pCR based on whole-tumor radiomics (ModelWH), intravoxel incoherent motion-based habitat imaging (ModelHabitats), conventional MRI features (ModelCF), and immunohistochemical findings (ModelIHC).
Results: In the prediction of pCR, ModelWH, ModelHabitats, ModelCF, ModelIHC, ModelHabitats+CF, and ModelHabitats+CF+IHC achieved AUCs of 0.549, 0.708, 0.700, 0.788, 0.745, and 0.891 respectively, in the test set.
Impact: The habitat model combined with conventional MRI features and IHC findings accurately predicted pCR before NAC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords